• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Braskem SA ADR

    4/29/25 6:19:30 AM ET
    $BAK
    Major Chemicals
    Industrials
    Get the next $BAK alert in real time by email
    6-K 1 bak20250428_6k2.htm 6-K

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     


     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16
    OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934


    For the month of April, 2025

    (Commission File No. 1-14862 )

     


     

    BRASKEM S.A.

    (Exact Name as Specified in its Charter)

     

    N/A

    (Translation of registrant's name into English)

     


     

    Rua Eteno, 1561, Polo Petroquimico de Camacari
    Camacari, Bahia - CEP 42810-000 Brazil

    (Address of principal executive offices)

     


     

    Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

    Form 20-F ___X___       Form 40-F ______

     

    Indicate by check mark if the registrant is submitting the Form 6-K
    in paper as permitted by Regulation S-T Rule 101(b)(1). _____

     

    Indicate by check mark if the registrant is submitting the Form 6-K
    in paper as permitted by Regulation S-T Rule 101(b)(7). _____

     

    Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

    Yes ______       No ___X___

    If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.

     

     
     

     

    BRASKEM S.A

    C.N.P.J. No. 42.150.391/0001-70

    NIRE 29300006939

    PUBLICLY HELD COMPANY

     

    ANNUAL GENERAL MEETING

    OF APRIL 28, 2025

     

    DETAILED FINAL VOTING MAP

     

    São Paulo, April 28, 2025 – Braskem S.A. (B3: BRKM3, BRKM5 and BRKM6; NYSE: BAK; LATIBEX: XBRK) (“Company”), in compliance with CVM Resolution No. 81/22, as amended, hereby disclose to its shareholders and the market the detailed final voting map which consolidates the voting instructions of both shareholders which voted through remote voting (boletim de voto a distância) and those during the Meeting, as computed at the Annual General Meeting of the Company held on April 28, 2025, including the first five digits of the shareholders’ individual or corporate taxpayer identification number (CPF or CNPJ, respectively), their vote on each item, and information about their shareholding position, as EXHIBIT I.

    Further information can be obtained from Braskem’s Investor Relations Department by phone: +55 (11) 3576-9531 or by e-mail: [email protected]

     

    1 
     

     

     

    EXHIBIT I

    ANNUAL GENERAL MEETING

    OF APRIL 28, 2025

     

    DETAILED FINAL VOTING MAP

    Code of the Resolution Description of the Resolution CNPJ/CPF (first 5 digits) Vote Number of Shares
    Number of Common Shares Number of Preferred Shares
    Annual General Meeting
    1 Examination, discussion, and voting on the Company’s Financial Statements, accompanied by the report and opinion of the Independent Auditors, the opinion of the Fiscal Council, and the report of the Statutory Compliance and Audit Committee, for the fiscal year ended December 31, 2024. 05457 APPROVE 3,633,062 -
    33000 APPROVE 212,426,952 75,761,739
    22606 APPROVE 226,334,622 79,182,486
    05144 APPROVE 1 12
    08935 ABSTAIN 4,192,800 1,280,690
    76423 APPROVE 6 -
    05523 APPROVE - 6,058,166
    05523 REJECT - 1,466,998
    05523 ABSTAIN - 4,025,180
    00708 APPROVE -  
    00837 APPROVE 1,000 1,500
    02055 ABSTAIN - 543
    02667 APPROVE 2 10
    02858 APPROVE - 2
    03332 APPROVE - 2
    03700 ABSTAIN 50 -
    04741 REJECT 1,000 -
    04879 APPROVE 1,400 -
    05076 APPROVE - 185
    05889 APPROVE - 20,000
    06051 APPROVE - 70
    06164 APPROVE - 2,160
    07948 APPROVE - 20
    08273 ABSTAIN - 70
    09504 APPROVE - 800
    13301 APPROVE 38 -
    13511 ABSTAIN - 53
    22450 ABSTAIN - 700
    28221 APPROVE - 123
    32501 APPROVE - 1
    32721 APPROVE - -
    37470 ABSTAIN - 24
    38856 APPROVE - 15
    46390 APPROVE 10 30
    51832 APPROVE - 300
    54868 APPROVE 10 -
    60749 APPROVE - 200
    89147 APPROVE - 2
    05479 APPROVE - 744
    05479 REJECT - 334,331
    05839 REJECT - 219,855
    05839 REJECT - 23,853,565
    05839 REJECT - 74,800
    05839 REJECT - 498,100
    05840 REJECT - 6,131
    05987 REJECT - 1,547
    05987 REJECT - 14,300
    05987 APPROVE - 90,100
    06239 APPROVE - 29,100
    07140 REJECT - -
    07208 REJECT - 9,700
    07247 APPROVE - 32,900
    07418 REJECT - 30,200
    07496 REJECT - 398,294
    07516 APPROVE - 22,553
    07622 APPROVE - 546,686
    09063 APPROVE - 213,809
    09233 APPROVE - 48,380
    09299 REJECT - 167,200
    09349 REJECT - 45,700
    09470 REJECT - 120,686
    09470 REJECT - 64,800
    09559 REJECT - 96,180
    09620 APPROVE - 43,060
    10205 REJECT - 351
    10327 REJECT - 50,900
    10492 APPROVE - 1,587,835
    10916 APPROVE - 62,607
    11100 APPROVE - 251,326
    11311 APPROVE - 114,081
    11324 APPROVE - 17,886
    11841 APPROVE - 410,231
    12094 REJECT - 58,500
    12120 APPROVE - 89,500
    13362 REJECT - 47,100
    14494 APPROVE - 14,910
    14541 REJECT - 104,500
    17718 REJECT - 449,302
    19874 REJECT - 145,700
    20622 REJECT - 89,100
    20813 REJECT - 92,159
    20849 REJECT - 600
    21962 REJECT - 47,400
    22403 REJECT - 1,040,000
    22420 REJECT - 196,300
    23442 REJECT - 79,895
    23847 REJECT - 391,589
    24935 APPROVE - 104,919
    26160 REJECT - 4,100
    26311 REJECT - 4,100
    26784 REJECT - 3,600
    27624 REJECT - 48,646
    27714 APPROVE - 300,034
    27778 REJECT - 25,990
    28394 REJECT - 19,700
    28990 REJECT - -
    29322 REJECT - 1,887,969
    31577 REJECT - 9,000
    31989 REJECT - 85,708
    32106 APPROVE - 2,750
    32329 REJECT - 150,336
    33580 REJECT - 5,500
    33814 REJECT - -
    34900 REJECT - 13,100
    35693 REJECT - 1,425,600
    37339 APPROVE - 460,993
    38756 REJECT - 41,200
    43533 REJECT - 9,453
    44602 REJECT - -
    44700 REJECT - 7,064
    45226 REJECT - 83,015
    45919 REJECT - 125,323
    46375 APPROVE - 28,225
    46406 ABSTAIN - 188,200
    46981 REJECT - 6
    48185 REJECT - 11,601
    51028 REJECT - 874
    53176 APPROVE - 7,838
    54423 REJECT - 76,382
    55912 REJECT - 300
    97540 REJECT - 2,186,483

     

    2 
     

     

     

     

     

     

     

    2 Examination, discussion, and voting on the Management Report and the respective accounts of the directors for the fiscal year ended December 31, 2024. 05457 APPROVE 3,633,062 -
    33000 APPROVE 212,426,952 75,761,739
    22606 APPROVE 226,334,622 79,182,486
    05144 APPROVE 1 12
    08935 ABSTAIN 4,192,800 1,280,690
    76423 APPROVE 6 -
    05523 APPROVE - 6,082,144
    05523 REJECT - 1,440,806
    05523 ABSTAIN - 4,006,124
    00708 APPROVE -  
    00837 APPROVE 1,000 1,500
    02055 ABSTAIN - 543
    02667 APPROVE 2 10
    02858 APPROVE - 2
    03332 APPROVE - 2
    03700 ABSTAIN 50 -
    04741 REJECT 1,000 -
    04879 APPROVE 1,400 -
    05076 APPROVE - 185
    05889 APPROVE - 20,000
    06051 APPROVE - 70
    06164 APPROVE - 2,160
    07948 APPROVE - 20
    08273 ABSTAIN - 70
    09504 APPROVE - 800
    13301 APPROVE 38 -
    13511 ABSTAIN - 53
    22450 ABSTAIN - 700
    28221 APPROVE - 123
    32501 APPROVE - 1
    32721 APPROVE - -
    37470 ABSTAIN - 24
    38856 APPROVE - 15
    46390 APPROVE 10 30
    51832 APPROVE - 300
    54868 APPROVE 10 -
    60749 APPROVE - 200
    89147 APPROVE - 2
    05479 APPROVE - 744
    05479 REJECT - 334,331
    05839 REJECT - 219,855
    05839 REJECT - 23,853,565
    05839 REJECT - 74,800
    05839 REJECT - 498,100
    05840 REJECT - 6,131
    05987 REJECT - 1,547
    05987 REJECT - 14,300
    05987 APPROVE - 90,100
    06239 APPROVE - 29,100
    07140 REJECT - -
    07208 REJECT - 9,700
    07247 APPROVE - 32,900
    07418 REJECT - 30,200
    07496 REJECT - 398,294
    07516 APPROVE - 22,553
    07622 APPROVE - 546,686
    09063 APPROVE - 213,809
    09233 APPROVE - 48,380
    09299 REJECT - 167,200
    09349 REJECT - 45,700
    09470 REJECT - 120,686
    09470 REJECT - 64,800
    09559 REJECT - 96,180
    09620 APPROVE - 43,060
    10205 REJECT - 351
    10327 REJECT - 50,900
    10492 APPROVE - 1,587,835
    10916 APPROVE - 62,607
    11100 APPROVE - 251,326
    11311 APPROVE - 114,081
    11324 APPROVE - 17,886
    11841 APPROVE - 410,231
    12094 REJECT - 58,500
    12120 APPROVE - 89,500
    13362 REJECT - 47,100
    14494 APPROVE - 14,910
    14541 REJECT - 104,500
    17718 REJECT - 449,302
    19874 REJECT - 145,700
    20622 REJECT - 89,100
    20813 REJECT - 92,159
    20849 REJECT - 600
    21962 REJECT - 47,400
    22403 REJECT - 1,040,000
    22420 REJECT - 196,300
    23442 REJECT - 79,895
    23847 REJECT - 391,589
    24935 APPROVE - 104,919
    26160 REJECT - 4,100
    26311 REJECT - 4,100
    26784 REJECT - 3,600
    27624 REJECT - 48,646
    27714 APPROVE - 300,034
    27778 REJECT - 25,990
    28394 REJECT - 19,700
    28990 REJECT - -
    29322 REJECT - 1,887,969
    31577 REJECT - 9,000
    31989 REJECT - 85,708
    32106 APPROVE - 2,750
    32329 REJECT - 150,336
    33580 REJECT - 5,500
    33814 REJECT - -
    34900 REJECT - 13,100
    35693 REJECT - 1,425,600
    37339 APPROVE - 460,993
    38756 REJECT - 41,200
    43533 REJECT - 9,453
    44602 REJECT - -
    44700 REJECT - 7,064
    45226 REJECT - 83,015
    45919 REJECT - 125,323
    46375 APPROVE - 28,225
    46406 ABSTAIN - 188,200
    46981 REJECT - 6
    48185 REJECT - 11,601
    51028 REJECT - 874
    53176 APPROVE - 7,838
    54423 REJECT - 76,382
    55912 REJECT - 300
    97540 REJECT - 2,186,483

     

    3 
     

     

     

     

     

     

     

    3 Nomination of all the names that compose the slate. - Eleição Majoritária 05457 APPROVE 3,633,062 -
    33000 APPROVE 212,426,952 75,761,739
    22606 APPROVE 226,334,622 79,182,486
    05144 APPROVE 1 12
    08935 ABSTAIN 4,192,800 1,280,690
    76423 ABSTAIN 6 -
    05523 APPROVE - 7,151,174
    05523 REJECT - 301,062
    05523 ABSTAIN - 4,077,460
    00708 APPROVE -  
    00837 APPROVE 1,000 1,500
    02055 ABSTAIN - 543
    02667 APPROVE 2 10
    02858 APPROVE - 2
    03332 APPROVE - 2
    03700 APPROVE 50 -
    04741 REJECT 1,000 -
    04879 APPROVE 1,400 -
    05076 APPROVE - 185
    05889 ABSTAIN - 20,000
    06051 ABSTAIN - 70
    06164 REJECT - 2,160
    07948 APPROVE - 20
    08273 ABSTAIN - 70
    09504 APPROVE - 800
    13301 APPROVE 38 -
    13511 ABSTAIN - 53
    22450 ABSTAIN - 700
    28221 REJECT - 123
    32501 APPROVE - 1
    32721 APPROVE - -
    37470 ABSTAIN - 24
    38856 APPROVE - 15
    46390 APPROVE 10 30
    51832 APPROVE - 300
    54868 APPROVE 10 -
    60749 APPROVE - 200
    89147 APPROVE - 2
    05479 APPROVE - 744
    05479 APPROVE - 334,331
    05839 APPROVE - 219,855
    05839 APPROVE - 23,853,565
    05839 APPROVE - 74,800
    05839 APPROVE - 498,100
    05840 APPROVE - 6,131
    05987 APPROVE - 1,547
    05987 APPROVE - 14,300
    05987 APPROVE - 90,100
    06239 APPROVE - 29,100
    07140 APPROVE - -
    07208 APPROVE - 9,700
    07247 APPROVE - 32,900
    07418 APPROVE - 30,200
    07496 APPROVE - 398,294
    07516 APPROVE - 22,553
    07622 APPROVE - 546,686
    09063 APPROVE - 213,809
    09233 APPROVE - 48,380
    09299 APPROVE - 167,200
    09349 APPROVE - 45,700
    09470 APPROVE - 120,686
    09470 APPROVE - 64,800
    09559 APPROVE - 96,180
    09620 APPROVE - 43,060
    10205 APPROVE - 351
    10327 APPROVE - 50,900
    10492 APPROVE - 1,587,835
    10916 APPROVE - 62,607
    11100 APPROVE - 251,326
    11311 APPROVE - 114,081
    11324 APPROVE - 17,886
    11841 APPROVE - 410,231
    12094 APPROVE - 58,500
    12120 APPROVE - 89,500
    13362 APPROVE - 47,100
    14494 APPROVE - 14,910
    14541 APPROVE - 104,500
    17718 APPROVE - 449,302
    19874 APPROVE - 145,700
    20622 APPROVE - 89,100
    20813 APPROVE - 92,159
    20849 APPROVE - 600
    21962 APPROVE - 47,400
    22403 APPROVE - 1,040,000
    22420 APPROVE - 196,300
    23442 APPROVE - 79,895
    23847 APPROVE - 391,589
    24935 APPROVE - 104,919
    26160 APPROVE - 4,100
    26311 APPROVE - 4,100
    26784 APPROVE - 3,600
    27624 APPROVE - 48,646
    27714 APPROVE - 300,034
    27778 APPROVE - 25,990
    28394 APPROVE - 19,700
    28990 APPROVE - -
    29322 APPROVE - 1,887,969
    31577 APPROVE - 9,000
    31989 APPROVE - 85,708
    32106 APPROVE - 2,750
    32329 APPROVE - 150,336
    33580 APPROVE - 5,500
    33814 APPROVE - -
    34900 APPROVE - 13,100
    35693 APPROVE - 1,425,600
    37339 APPROVE - 460,993
    38756 APPROVE - 41,200
    43533 APPROVE - 9,453
    44602 APPROVE - -
    44700 APPROVE - 7,064
    45226 APPROVE - 83,015
    45919 APPROVE - 125,323
    46375 APPROVE - 28,225
    46406 REJECT - 188,200
    46981 APPROVE - 6
    48185 APPROVE - 11,601
    51028 APPROVE - 874
    53176 APPROVE - 7,838
    54423 APPROVE - 76,382
    55912 APPROVE - 300
    97540 APPROVE - 2,186,483

     

    4 
     

     

     

     

     

     

     

    4 If one of the candidates of the slate leaves it, to accommodate the separate election referred to in articles 161, paragraph 4, and 240 of Law 6404, of 1976, can the votes corresponding to your shares continue to be conferred to the same slate? 05457 YES 3,633,062 -
    05523 YES - 5,656,756
    05523 NO - 1,812,516
    05523 ABSTAIN - 4,056,424
    00708 YES -  
    00837 NO 1,000 1,500
    02055 ABSTAIN - 543
    02667 YES 2 10
    02858 YES - 2
    03332 YES - 2
    03700 YES 50 -
    04741 NO 1,000 -
    04879 YES 1,400 -
    05076 NO - 185
    05889 ABSTAIN - 20,000
    06051 ABSTAIN - 70
    06164 NO - 2,160
    07948 NO - 20
    08273 ABSTAIN - 70
    09504 YES - 800
    13301 ABSTAIN 38 -
    13511 ABSTAIN - 53
    22450 ABSTAIN - 700
    28221 YES - 123
    32501 YES - 1
    32721 YES - -
    37470 ABSTAIN - 24
    38856 YES - 15
    46390 YES 10 30
    51832 YES - 300
    54868 YES 10 -
    60749 YES - 200
    89147 YES - 2
    05479 NO - 744
    05479 NO - 334,331
    05839 NO - 219,855
    05839 NO - 23,853,565
    05839 NO - 74,800
    05839 NO - 498,100
    05840 NO - 6,131
    05987 NO - 1,547
    05987 NO - 14,300
    05987 NO - 90,100
    06239 NO - 29,100
    07140 NO - -
    07208 NO - 9,700
    07247 YES - 32,900
    07418 NO - 30,200
    07496 NO - 398,294
    07516 NO - 22,553
    07622 NO - 546,686
    09063 ABSTAIN - 213,809
    09233 NO - 48,380
    09299 NO - 167,200
    09349 NO - 45,700
    09470 NO - 120,686
    09470 NO - 64,800
    09559 NO - 96,180
    09620 NO - 43,060
    10205 NO - 351
    10327 NO - 50,900
    10492 ABSTAIN - 1,587,835
    10916 NO - 62,607
    11100 NO - 251,326
    11311 NO - 114,081
    11324 ABSTAIN - 17,886
    11841 NO - 410,231
    12094 NO - 58,500
    12120 NO - 89,500
    13362 NO - 47,100
    14494 NO - 14,910
    14541 NO - 104,500
    17718 NO - 449,302
    19874 NO - 145,700
    20622 NO - 89,100
    20813 NO - 92,159
    20849 NO - 600
    21962 NO - 47,400
    22403 NO - 1,040,000
    22420 NO - 196,300
    23442 NO - 79,895
    23847 NO - 391,589
    24935 NO - 104,919
    26160 NO - 4,100
    26311 NO - 4,100
    26784 NO - 3,600
    27624 NO - 48,646
    27714 ABSTAIN - 300,034
    27778 NO - 25,990
    28394 NO - 19,700
    28990 NO - -
    29322 NO - 1,887,969
    31577 NO - 9,000
    31989 NO - 85,708
    32106 NO - 2,750
    32329 NO - 150,336
    33580 NO - 5,500
    33814 NO - -
    34900 NO - 13,100
    35693 NO - 1,425,600
    37339 NO - 460,993
    38756 NO - 41,200
    43533 NO - 9,453
    44602 NO - -
    44700 NO - 7,064
    45226 NO - 83,015
    45919 NO - 125,323
    46375 NO - 28,225
    46406 NO - 188,200
    46981 NO - 6
    48185 NO - 11,601
    51028 NO - 874
    53176 ABSTAIN - 7,838
    54423 NO - 76,382
    55912 NO - 300
    97540 NO - 2,186,483
    5 Would you like to request a separate election by minority shareholders holding common shares for a member of the Fiscal Council, pursuant to Article 161, §4, a of the Brazilian Corporation Law? 05457 ABSTAIN 3,633,062 -
    08935 APPROVE 4,192,800 1,280,690
    00837 APPROVE 1,000 1,500
    02667 APPROVE 2 10
    03700 APPROVE 50 -
    04741 REJECT 1,000 -
    04879 APPROVE 1,400 -
    13301 ABSTAIN 38 -
    46390 APPROVE 10 30
    54868 APPROVE 10 -

     

    5 
     

     

     

     

     

     

     

    6 Would you like to request a separate election by minority shareholders holding preferred shares for a member of the Fiscal Council, pursuant to Article 161, §4, a of the Brazilian Corporation Law? 08935 APPROVE 4,192,800 1,280,690
    05523 APPROVE - 10,790,858
    05523 REJECT - 147,188
    05523 ABSTAIN - 587,022
    00708 APPROVE -  
    00837 APPROVE 1,000 1,500
    02055 ABSTAIN - 543
    02667 APPROVE 2 10
    02858 APPROVE - 2
    03332 APPROVE - 2
    05076 APPROVE - 185
    05889 ABSTAIN - 20,000
    06051 ABSTAIN - 70
    06164 APPROVE - 2,160
    07948 APPROVE - 20
    08273 ABSTAIN - 70
    09504 APPROVE - 800
    13511 ABSTAIN - 53
    22450 ABSTAIN - 700
    28221 APPROVE - 123
    32501 APPROVE - 1
    32721 APPROVE - -
    37470 ABSTAIN - 24
    38856 APPROVE - 15
    46390 APPROVE 10 30
    51832 APPROVE - 300
    60749 APPROVE - 200
    89147 APPROVE - 2
    05479 REJECT - 744
    05479 APPROVE - 334,331
    05839 APPROVE - 219,855
    05839 APPROVE - 23,853,565
    05839 APPROVE - 74,800
    05839 APPROVE - 498,100
    05840 APPROVE - 6,131
    05987 APPROVE - 1,547
    05987 APPROVE - 14,300
    05987 REJECT - 90,100
    06239 REJECT - 29,100
    07140 APPROVE - -
    07208 APPROVE - 9,700
    07247 APPROVE - 32,900
    07418 APPROVE - 30,200
    07496 APPROVE - 398,294
    07516 APPROVE - 22,553
    07622 APPROVE - 546,686
    09063 ABSTAIN - 213,809
    09233 APPROVE - 48,380
    09299 APPROVE - 167,200
    09349 APPROVE - 45,700
    09470 APPROVE - 120,686
    09470 APPROVE - 64,800
    09559 APPROVE - 96,180
    09620 APPROVE - 43,060
    10205 APPROVE - 351
    10327 APPROVE - 50,900
    10492 ABSTAIN - 1,587,835
    10916 REJECT - 62,607
    11100 ABSTAIN - 251,326
    11311 APPROVE - 114,081
    11324 ABSTAIN - 17,886
    11841 APPROVE - 410,231
    12094 APPROVE - 58,500
    12120 ABSTAIN - 89,500
    13362 APPROVE - 47,100
    14494 APPROVE - 14,910
    14541 APPROVE - 104,500
    17718 APPROVE - 449,302
    19874 APPROVE - 145,700
    20622 APPROVE - 89,100
    20813 APPROVE - 92,159
    20849 APPROVE - 600
    21962 APPROVE - 47,400
    22403 APPROVE - 1,040,000
    22420 APPROVE - 196,300
    23442 APPROVE - 79,895
    23847 APPROVE - 391,589
    24935 APPROVE - 104,919
    26160 APPROVE - 4,100
    26311 APPROVE - 4,100
    26784 APPROVE - 3,600
    27624 APPROVE - 48,646
    27714 ABSTAIN - 300,034
    27778 APPROVE - 25,990
    28394 APPROVE - 19,700
    28990 APPROVE - -
    29322 APPROVE - 1,887,969
    31577 APPROVE - 9,000
    31989 APPROVE - 85,708
    32106 ABSTAIN - 2,750
    32329 APPROVE - 150,336
    33580 APPROVE - 5,500
    33814 APPROVE - -
    34900 APPROVE - 13,100
    35693 APPROVE - 1,425,600
    37339 APPROVE - 460,993
    38756 APPROVE - 41,200
    43533 APPROVE - 9,453
    44602 APPROVE - -
    44700 APPROVE - 7,064
    45226 APPROVE - 83,015
    45919 APPROVE - 125,323
    46375 APPROVE - 28,225
    46406 APPROVE - 188,200
    46981 APPROVE - 6
    48185 APPROVE - 11,601
    51028 APPROVE - 874
    53176 ABSTAIN - 7,838
    54423 APPROVE - 76,382
    55912 APPROVE - 300
    97540 APPROVE - 2,186,483
    7 Nomination of candidates to the supervisory board by shareholders holding preferred shares without voting rights or with restricted voting rights DANIEL STIELER / OCTAVIO LEBARBENCHON 08935 APPROVE 4,192,800 1,280,690

     

    6 
     

     

     

     

     

     

     

    8 To deliberate on the annual and global compensation limit for the directors and members of the Fiscal Council of the Company for the fiscal year ending on December 31, 2024. 05457 APPROVE 3,633,062 -
    33000 APPROVE 212,426,952 75,761,739
    22606 APPROVE 226,334,622 79,182,486
    05144 APPROVE 1 12
    08935 ABSTAIN 4,192,800 1,280,690
    76423 APPROVE 6 -
    05523 APPROVE - 6,339,878
    05523 REJECT - 1,137,882
    05523 ABSTAIN - 4,052,710
    00708 APPROVE -  
    00837 APPROVE 1,000 1,500
    02055 ABSTAIN - 543
    02667 APPROVE 2 10
    02858 APPROVE - 2
    03332 APPROVE - 2
    03700 APPROVE 50 -
    04741 REJECT 1,000 -
    04879 APPROVE 1,400 -
    05076 APPROVE - 185
    05889 APPROVE - 20,000
    06051 ABSTAIN - 70
    06164 REJECT - 2,160
    07948 APPROVE - 20
    08273 ABSTAIN - 70
    09504 APPROVE - 800
    13301 APPROVE 38 -
    13511 ABSTAIN - 53
    22450 ABSTAIN - 700
    28221 APPROVE - 123
    32501 APPROVE - 1
    32721 APPROVE - -
    37470 ABSTAIN - 24
    38856 APPROVE - 15
    46390 APPROVE 10 30
    51832 APPROVE - 300
    54868 APPROVE 10 -
    60749 APPROVE - 200
    89147 APPROVE - 2
    05479 APPROVE - 744
    05479 REJECT - 334,331
    05839 REJECT - 219,855
    05839 APPROVE - 23,853,565
    05839 REJECT - 74,800
    05839 REJECT - 498,100
    05840 REJECT - 6,131
    05987 REJECT - 1,547
    05987 REJECT - 14,300
    05987 APPROVE - 90,100
    06239 APPROVE - 29,100
    07140 REJECT - -
    07208 REJECT - 9,700
    07247 APPROVE - 32,900
    07418 REJECT - 30,200
    07496 REJECT - 398,294
    07516 APPROVE - 22,553
    07622 APPROVE - 546,686
    09063 REJECT - 213,809
    09233 APPROVE - 48,380
    09299 REJECT - 167,200
    09349 REJECT - 45,700
    09470 REJECT - 120,686
    09470 REJECT - 64,800
    09559 REJECT - 96,180
    09620 APPROVE - 43,060
    10205 REJECT - 351
    10327 REJECT - 50,900
    10492 REJECT - 1,587,835
    10916 REJECT - 62,607
    11100 APPROVE - 251,326
    11311 APPROVE - 114,081
    11324 REJECT - 17,886
    11841 APPROVE - 410,231
    12094 REJECT - 58,500
    12120 APPROVE - 89,500
    13362 REJECT - 47,100
    14494 APPROVE - 14,910
    14541 REJECT - 104,500
    17718 REJECT - 449,302
    19874 REJECT - 145,700
    20622 REJECT - 89,100
    20813 REJECT - 92,159
    20849 REJECT - 600
    21962 REJECT - 47,400
    22403 REJECT - 1,040,000
    22420 REJECT - 196,300
    23442 REJECT - 79,895
    23847 REJECT - 391,589
    24935 APPROVE - 104,919
    26160 REJECT - 4,100
    26311 REJECT - 4,100
    26784 REJECT - 3,600
    27624 APPROVE - 48,646
    27714 REJECT - 300,034
    27778 REJECT - 25,990
    28394 REJECT - 19,700
    28990 REJECT - -
    29322 REJECT - 1,887,969
    31577 REJECT - 9,000
    31989 REJECT - 85,708
    32106 REJECT - 2,750
    32329 REJECT - 150,336
    33580 REJECT - 5,500
    33814 REJECT - -
    34900 REJECT - 13,100
    35693 REJECT - 1,425,600
    37339 APPROVE - 460,993
    38756 REJECT - 41,200
    43533 REJECT - 9,453
    44602 REJECT - -
    44700 REJECT - 7,064
    45226 REJECT - 83,015
    45919 APPROVE - 125,323
    46375 APPROVE - 28,225
    46406 REJECT - 188,200
    46981 REJECT - 6
    48185 REJECT - 11,601
    51028 APPROVE - 874
    53176 REJECT - 7,838
    54423 REJECT - 76,382
    55912 REJECT - 300
        97540 REJECT - 2,186,483
                 

     

     

     

     

    7 

    SIGNATURES

            Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

    Date: April 28, 2025

      BRASKEM S.A.
           
           
      By:      /s/     Felipe Montoro Jens
         
        Name: Felipe Montoro Jens
        Title: Chief Financial Officer

     

    DISCLAIMER ON FORWARD-LOOKING STATEMENTS

     

    This report on Form 6-K may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are statements that are not historical facts, and are based on our management’s current view and estimates of future economic and other circumstances, industry conditions, company performance and financial results, including any potential or projected impact of the geological event in Alagoas and related legal proceedings and of COVID-19 on our business, financial condition and operating results. The words “anticipates,” “believes,” “estimates,” “expects,” “plans” and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the potential outcome of legal and administrative proceedings, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting our financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of our management and are subject to a number of risks and uncertainties, many of which are outside of the our control. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors, including the projected impact of the geological event in Alagoas and related legal proceedings and the unprecedented impact of COVID-19 pandemic on our business, employees, service providers, stockholders, investors and other stakeholders, could cause actual results to differ materially from current expectations. Please refer to our annual report on Form 20-F for the year ended December 31, 2019 filed with the SEC, as well as any subsequent filings made by us pursuant to the Exchange Act, each of which is available on the SEC’s website (www.sec.gov), for a full discussion of the risks and other factors that may impact any forward-looking statements in this presentation.


     

     

     

    Get the next $BAK alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BAK

    DatePrice TargetRatingAnalyst
    9/26/2025$3.80Buy → Neutral
    UBS
    3/3/2025Sector Outperform → Sector Perform
    Scotiabank
    9/18/2024Neutral → Buy
    UBS
    8/20/2024Neutral → Buy
    Citigroup
    8/29/2023Neutral → Sell
    UBS
    7/5/2023$11.50 → $11.00Overweight → Neutral
    JP Morgan
    6/14/2023Hold → Buy
    HSBC Securities
    5/18/2023Buy → Neutral
    UBS
    More analyst ratings

    $BAK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    From Air to Plastics: Norsk e-Fuel and Braskem Partner to Turn Captured Carbon into Long-Lasting Products

    Norsk e-Fuel AS, a pioneer in Power-to-Liquid (PtL) technology, and Braskem, a global leader in polymers and biopolymers, have announced a strategic collaboration to explore the possible integration of e-Naphtha into the plastics value chain. This partnership aims to accelerate the development of plastics derived from carbon that would otherwise be released into the atmosphere, reinforcing both companies' commitment to a circular future. Norsk e-Fuel is driving the industrial rollout of PtL technology by building large-scale facilities that convert fossil-free electricity, water, and captured CO₂ into synthetic fuels and feedstocks. The company's plan foresees at least three plants in ope

    11/20/25 4:00:00 AM ET
    $BAK
    Major Chemicals
    Industrials

    With Braskem's I'm green™ bio-based Polyethylene, Balsam Hill Made the World's First Plant-Based Plastic Christmas Trees

    Braskem (B3: BRKM3, BRKM5, and BRKM6, NYSE:BAK, LATIBEX: XBRK), the largest polyolefins producer in the Americas and global leader in the production of biopolymers on an industrial scale, and Balsam Hill®, the global leader in high-quality, true-to-nature, reusable artificial Christmas trees and holiday décor, are excited to introduce the world's first Christmas trees made with plant-based plastic. For Balsam Hill, these trees are an important part of the company's reNEW™ commitment to move towards new and more sustainable materials (recycled or renewable), starting with trees. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202510

    10/27/25 8:00:00 AM ET
    $BAK
    Major Chemicals
    Industrials

    Braskem Unveils Bio-based Product Innovations at K 2025

    Braskem, a market leader in the production of biopolymers on an industrial scale, is currently at K 2025, the world's leading trade fair for plastics and rubber in Düsseldorf, Germany. On the opening day, Braskem showcased a new generation of bio-based and circular product solutions aimed at accelerating the transformation of the plastics industry. Under its sustainable portfolio, Braskem is revealing product launches and partnerships that bring sustainability and innovation to life across packaging, healthcare, hygiene, and consumer goods. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251009859755/en/I'm green bio-based polyet

    10/9/25 4:00:00 AM ET
    $BAK
    Major Chemicals
    Industrials

    $BAK
    SEC Filings

    View All

    SEC Form 6-K filed by Braskem SA ADR

    6-K - BRASKEM SA (0001071438) (Filer)

    2/9/26 5:21:29 PM ET
    $BAK
    Major Chemicals
    Industrials

    SEC Form 6-K filed by Braskem SA ADR

    6-K - BRASKEM SA (0001071438) (Filer)

    2/9/26 4:12:36 PM ET
    $BAK
    Major Chemicals
    Industrials

    SEC Form 6-K filed by Braskem SA ADR

    6-K - BRASKEM SA (0001071438) (Filer)

    2/9/26 4:10:18 PM ET
    $BAK
    Major Chemicals
    Industrials

    $BAK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Braskem SA downgraded by UBS with a new price target

    UBS downgraded Braskem SA from Buy to Neutral and set a new price target of $3.80

    9/26/25 8:01:31 AM ET
    $BAK
    Major Chemicals
    Industrials

    Braskem SA downgraded by Scotiabank

    Scotiabank downgraded Braskem SA from Sector Outperform to Sector Perform

    3/3/25 7:16:10 AM ET
    $BAK
    Major Chemicals
    Industrials

    Braskem SA upgraded by UBS

    UBS upgraded Braskem SA from Neutral to Buy

    9/18/24 7:29:50 AM ET
    $BAK
    Major Chemicals
    Industrials

    $BAK
    Financials

    Live finance-specific insights

    View All

    Braskem and Oxiteno sign a partnership to supply bio-attributed ethylene

    Oxiteno will receive Braskem's certified raw material for the production of new sustainable solutions, providing a breakthrough in the Brazilian chemical industry. Committed to supporting the circular economy and fighting climate change, Brazilian petrochemical companies Braskem and Indorama Ventures IOD - Oxiteno announce a partnership to supply bio-attributed ethylene from renewable sources. Bio-attributed ethylene, certified by ISCC (International Sustainability and Carbon Certification), will be used by Oxiteno to create new sustainable solutions. This raw material is the first bio-attributed chemical product produced by Braskem from the certified mass balance approach. The concep

    11/6/23 8:00:00 AM ET
    $BAK
    Major Chemicals
    Industrials

    Origin Materials, Inc. Reports Operating and Financial Results for Second Quarter 2023

    – Origin 1 Initiated Start-Up, In-Line with Prior Guidance – – FDCA Mass Production Moves Forward to Origin 2, Rather Than Origin 3 as Initially Planned, Due to Strong Commercialization Progress and Higher-Margin Opportunities – – Origin 2 Outlook Updated; Phased Construction Plan Reduces Risk on Path to Profitability, with Phase 1 Start-Up Expected in Late 2026 to 2027, Phase 2 Start-Up Expected in 2028 – – Origin to Supply Para-Xylene for Bio-PET to Customers Prior to 2030 Primarily Through Collaborations with Strategic Partners – – Maintains 2023 Revenue and Adjusted EBITDA Outlook, Customer Demand Exceeds $10 Billion – Origin Materials, Inc. ("Origin," "Origin Materials," or t

    8/9/23 4:01:00 PM ET
    $BAK
    $ORGN
    Major Chemicals
    Industrials

    Braskem Acquires taulman3D Expanding its Portfolio of Materials for Additive Manufacturing Applications

    The acquisition of taulman3D further accelerates Braskem's growth strategy in the additive manufacturing market with a highly complementary portfolio of 3D materials trusted by professionals worldwide. taulman3D filaments and polymers are available globally, through distributors on 6 continents Braskem ((B3: BRKM3, BRKM5, and BRKM6, NYSE:BAK, LATIBEX: XBRK)) the largest polyolefins producer in the Americas, as well as a market leader and pioneer producer of biopolymers on an industrial scale, today announced the acquisition of taulman3D, a leading 3D filament supplier of nylon, recycled PETG, and PET filaments to aerospace, automotive, healthcare, industrial, government and higher educati

    1/4/23 8:00:00 AM ET
    $BAK
    Major Chemicals
    Industrials

    $BAK
    Leadership Updates

    Live Leadership Updates

    View All

    Empowering Brands with Bio-Based Innovation: Braskem Highlights I'm green™ bio-based Portfolio at Sustainable Brands

    I'm green™ bio-based will highlight its collaboration with forward-thinking brands to scale bio-based solutions globally Braskem's I'm green™ bio-based brand will participate in Sustainable Brands 2025, held in San Diego, Calif., from Oct. 13 to 16 to raise awareness about carbon footprint and its impact on climate change. Backed by more than 200 Life Cycle Assessments (LCAs) data, the company will engage in discussions and showcase how replacing traditional fossil-based materials with bio-based alternatives can significantly reduce carbon emissions and support the transition to a low-carbon circular economy. Attendees can explore I'm green™ bio-based at its booth, in program sessions,

    10/6/25 10:33:00 AM ET
    $BAK
    Major Chemicals
    Industrials